Signaling Pathways - Liver X receptors (LXRs) - MER - ATP Citrate Lyases - MK2
清除全部
- C5545 MK2 Inhibitor IVTarget: MK2Summary: 高选择性、非ATP竞争性MK2抑制剂
- A8714 SR-9243Target: Liver X receptors (LXRs)Summary: LXR反相激动剂
- B8016 UNC20251 CitationTarget: MER|FLT3Summary: 口服生物可利用的双重MER/FLT3抑制剂
- B6962 CMPD-1Target: Microtubules/Tubulins|MK2Summary: p38α介导的MK2a磷酸化的抑制剂
- B5549 PF-3644022Target: MK2Summary: MK2抑制剂
- B1079 BMS-303141Target: ATP Citrate LyasesSummary: 有效的ATP-柠檬酸裂合酶抑制剂
- B1264 LXR-6232 CitationTarget: Liver X receptors (LXRs)Summary: 肝X受体激动剂
- A2249 T0901317Target: Liver X receptors (LXRs)Summary: 肝X受体激动剂
- A3721 PHA-767491Target: Cyclin-Dependent Kinases|MK2|Cdc7Summary: Cdc7 / CDK9抑制剂
- A3454 GW39651 CitationTarget: Liver X receptors (LXRs)Summary: 高效选择性HLXRα/hLXRβ激动剂